Key result
NSTE-MINOCA links to ~157% higher major event risk versus STE-MINOCA, driven by cardiovascular rehospitalization.
Why the study?
The disparity between ST-segment elevation and non-ST-segment elevation myocardial infarction without obstructive coronary artery (STE-MINOCA and NSTE-MINOCA) was unclear.
Does NSTE-MINOCA presentation increase the risk of long-term adverse cardiovascular events compared to STE-MINOCA in patients with myocardial infarction with nonobstructive coronary arteries?
Cross-Sectional (n=107)
No
Does NSTE-MINOCA presentation increase the risk of long-term adverse cardiovascular events compared to STE-MINOCA in patients with myocardial infarction with nonobstructive coronary arteries?
Answers are grounded in this paper and cite their sources.
In patients with MINOCA, an NSTE presentation is associated with a significantly higher long-term risk of cardiovascular-related rehospitalization compared to an STE presentation.
BACKGROUND: The disparity between ST-segment and non-ST-segment elevation myocardial infarction without obstructive coronary artery (STE-MINOCA and NSTE-MINOCA) are unclear. Our study aims to compare the clinical features and outcomes in patients with STE-MINOCA and NSTE-MINOCA. METHODS: This cross-sectional study consecutively enrolled patients diagnosed with acute myocardial infarction (AMI) from January 2013 to January 2020. MINOCA were identified as angiographic stenosis < 50%. Clinical characteristics, angiographic features, and clinical outcomes of STE-MINOCA and NSTE-MINCOA were documented. The primary endpoint was composite events in the different time periods. RESULTS: A total of 1966 AMI patients were screened, 107 (5.4%) were diagnosed as MINOCA. Among, there were 34 (31.8%) of STE-MINOCA and 73 (68.2%) of NSTE-MINOCA. STE-MINOCA group were younger, had lower N-terminal pro-brain natriuretic peptide (NT-proBNP), and smaller left atrial diameter (P < 0.05). Dual antiplatelet therapy (DAPT) was more likely to be prescribed to STE-MINOCA patients (P = 0.015). During median follow-up time of 24.5 months, STE-MINOCA group also demonstrated lower risks for primary endpoint and cardiovascular-related (CVS) rehospitalization. In univariate Cox regression analyses, NSTE-MINOCA showed an increased risk of long-term primary endpoint (HR 2.57, 95 CI%: 1.10-6.02) and CVS-related rehospitalization (HR 3.14, 95% CI: 1.16-8.48). After adjusting for NT-proBNP and DAPT, NSTE-MINOCA remained an independent risk factor for CVS-related rehospitalization in long-term follow-up (HR 2.78, 95% CI: 1.03-7.49). CONCLUSION: Although STE-MINOCA and NSTE-MINOCA patients showed similar clinical characteristics, NSTE-MINOCA group presented a worse long-term outcome mainly driven by CVS-related hospitalization which suggested that NSTE-MINOCA patients might also require prompt medical attention.
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) conducted a cross-sectional in Myocardial infarction without obstructive coronary artery (MINOCA) (n=107). NSTE-MINOCA vs. STE-MINOCA was evaluated on Long-term composite events (all-cause mortality, heart failure, recurrence of AMI, cardiovascular-related rehospitalization, and stroke) (HR 2.57, 95% CI 1.10-6.02, p=0.030). NSTE-MINOCA was associated with an increased risk of long-term composite cardiovascular events compared to STE-MINOCA, primarily driven by cardiovascular-related rehospitalization.
Synapse has enriched 10 related papers. Consider them for comparative context: